Schomber et al. [261] reported an in vivo study of luteolin's ability to inhibit the growth of xenografted melanoma tumours in a mouse model induced by tumour cells BRAF-mt A375 and BRAF-wt WM3211 cells. Here, BRAF is linked to neoplasm.